$182 Million is the total value of Patient Square Capital LP's 2 reported holdings in Q3 2023. The portfolio turnover from Q2 2023 to Q3 2023 was 0.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| ROIVANT SCIENCES LTD | $147,634,266 | +15.9% | 12,639,920 | 0.0% | 81.13% | +30.8% | ||
| EARGO INC | $34,348,040 | -56.0% | 15,821,299 | 0.0% | 18.87% | -50.3% |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2023-11-14
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| ROIVANT SCIENCES LTD | 4 | Q3 2023 | 81.1% |
| EARGO INC | 3 | Q3 2023 | 59.5% |
| EARGO INC | 1 | Q4 2022 | 76.9% |
View Patient Square Capital LP's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-13 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-11 |
| 13F-HR | 2023-05-10 |
| 13F-HR | 2023-02-13 |
View Patient Square Capital LP's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.